10 Best Dividend Growth Stocks to Watch in April 2025: Investment Research Guide
Photo by Markus Winkler on Unsplash
- The S&P 500 fell nearly 19% from its February 2025 peak after sweeping tariff announcements — but dividend growth stocks cushioned the blow significantly better than the broader market.
- A top-10 high-growth dividend portfolio lost only 3.26% in March 2025, compared to SPY's 5.86% loss and VIG's 4.50% drop — a meaningful real-world outperformance.
- Goldman Sachs projected a 6% rise in S&P 500 dividend payouts for full-year 2025, signaling that corporate earnings were broadly healthy enough to keep raising dividends even under tariff pressure.
- The April 2025 high-growth dividend cohort traded at roughly 31% below estimated fair value, making several names worth researching for long-term total return potential.
What Happened
April 2025 was a stress test nobody ordered. The Trump administration's announcement of sweeping "reciprocal" tariffs on dozens of trading partners sent shockwaves through global markets. The S&P 500 fell nearly 19% from its February 2025 peak, briefly dipping below the 5,000 level for the first time since April 2024. For everyday investors, that kind of rapid decline can feel like a financial earthquake — the kind that triggers emotional selling and long-term regret.
But here is what the headline numbers missed: dividend growth stocks held up far better than the broader market. While market trends pointed toward panic, investors who owned high-quality dividend growers experienced a much smoother ride. A representative portfolio of the top 10 high-growth dividend stocks posted a loss of approximately 3.26% in March 2025, while the S&P 500 ETF (SPY) fell 5.86% and even the Vanguard Dividend Appreciation ETF (VIG) dropped 4.50%. That gap — roughly 2.6 percentage points versus SPY — is not a rounding error. Over time, those differences in drawdown compound into meaningful wealth preservation.
This kind of relative resilience is exactly why investment research into dividend growth strategies has gained renewed attention heading into the back half of 2025. When markets get choppy, companies that have the financial discipline to raise dividends year after year tend to be the ones with stronger balance sheets, more predictable cash flows, and better-managed operations. In volatile times, that consistency is worth paying close attention to.
What the Data Tells Us
The numbers behind the April 2025 dividend growth story reward careful stock analysis — and there are several layers worth unpacking.
Start with the macro picture. Goldman Sachs forecast a 6% increase in S&P 500 dividend payouts for full-year 2025, even as inflationary margin pressures squeezed sectors like Energy and Consumer Discretionary. That projection matters because it signals that corporate America was broadly generating enough free cash flow (money left over after paying operating costs and capital expenses) to keep returning capital to shareholders — even during a tariff-driven selloff.
Zoom into the sector analysis, and the data gets even more instructive. Excluding the Technology sector, the rest of the S&P 500 grew earnings by an average of 9.8% from Q1 through Q3 2025. That broad-based earnings growth is the underlying fuel that makes dividend sustainability possible. Companies can only reliably raise dividends if profits are growing underneath them — and by that measure, most of the market was in solid shape despite the volatility.
The April 2025 top-10 high-growth dividend list, as tracked by Seeking Alpha, carried an average dividend yield (annual dividend payment divided by share price) of approximately 1.25%. That may sound low compared to bonds or high-yield REITs, but that is intentional. Seeking Alpha contributors covering the cohort emphasized that the selection methodology "focuses on dividend growth and sustainability rather than high current yield," with final picks chosen based on sector diversity, high-growth quality scores, and positive momentum. These are stocks built for investors in the accumulation phase — people building wealth over time rather than drawing current income. The portfolio was assessed as roughly 31% undervalued relative to fair value estimates, representing a meaningful margin of safety (the gap between a stock's current price and its estimated true worth).
The Dividend Aristocrats — S&P 500 companies with 25 or more consecutive years of dividend increases — grew to 69 members as of early 2025, with three new additions: FactSet Research (FDS), Erie Indemnity (ERIE), and Eversource Energy (ES). These names carry an average dividend yield of 2.1% and represent the gold standard of dividend reliability, having maintained and grown their payouts through recessions, rate hike cycles, and multiple market crashes. For context on what that kind of consistency looks like in practice: Genuine Parts Company (GPC) declared its 69th consecutive annual dividend increase in February 2025 — a 3% raise. Sixty-nine years in a row. That track record tells investors something important about the company's financial culture and long-term discipline that no single quarterly earnings report can replicate.
Key Companies and Supply Chain
The sector analysis and supply chain positioning of these companies help explain why they appear on investor watchlists during periods of market stress — and what makes each one distinct.
ExxonMobil (XOM) — Energy
XOM yielded 3.3% in April 2025, with a 5-year annualized dividend growth rate of 2.3%. Its annual dividend of $3.96 per share is forecast to grow to $4.48 by 2028, according to analyst projections. As a vertically integrated energy major with exposure across the entire oil and gas supply chain — from upstream exploration and production to downstream refining, chemicals, and distribution — ExxonMobil has the operational scale to sustain dividends even through commodity price cycles. Investors are watching how tariff-driven energy cost shifts will affect margins in the years ahead.
Pfizer (PFE) — Healthcare
Pfizer yielded close to 7% in April 2025, making it one of the highest-yielding large-cap dividend growers on analyst watchlists. With a 5-year annualized dividend growth rate of 3.1%, Pfizer's pharmaceutical supply chain — spanning drug discovery, clinical manufacturing, and global distribution — provides a defensive income stream with global reach. Post-COVID revenue normalization has weighed on the share price, which is precisely why the yield looks elevated. The data suggests the dividend remains well-covered by operating cash flows, though ongoing stock analysis should track pipeline progress and cost structure.
Accenture (ACN) — Technology Services
Morningstar's April 2025 stock analysis placed Accenture at approximately 30% below its fair value estimate, with comprehensive AI-related service offerings cited as a key long-term growth driver. As enterprises accelerate digital transformation, Accenture occupies a critical position in the enterprise technology supply chain — the consulting and implementation layer that connects AI tools to real-world business operations. That positioning is increasingly difficult to replicate at scale.
PepsiCo (PEP) and Kimberly-Clark (KMB) — Consumer Staples
Morningstar analysts highlighted both companies as trading below fair value in April 2025, expecting mid-single-digit annual dividend growth going forward. Consumer staples businesses benefit from predictable demand regardless of broader market trends, making their dividends particularly durable across economic cycles. Investors are watching both as core accumulation-phase holdings.
Genuine Parts Company (GPC) — Industrials
With 69 consecutive years of dividend increases, GPC qualifies as a Dividend King (companies with 50 or more consecutive years of increases — an even rarer group than the Aristocrats). Its automotive and industrial parts distribution supply chain is deeply embedded in the U.S. economy, generating the steady, recurring cash flows that underpin its legendary dividend track record.
What Should You Do? 3 Action Steps
High current yield can sometimes be a warning sign — it often means a stock's price has fallen because something is wrong with the business, a pattern sometimes called a "yield trap." Investment research consistently shows that companies with strong dividend growth rates (5% or more annually) tend to generate superior long-term total returns. Look for stocks with a history of consistent annual raises, a payout ratio (the percentage of earnings paid as dividends) below 60%, and earnings growth that can support future increases. The April 2025 high-growth cohort's average 1.25% yield paired with strong growth credentials is a useful model to study before building your own watchlist.
The Vanguard Dividend Appreciation ETF (VIG) is a practical baseline for any dividend growth stock analysis. If individual stocks you are researching cannot plausibly outperform VIG over a full market cycle — including drawdowns like the March 2025 episode where VIG itself fell 4.50% — then the additional stock-picking complexity may not be worth the effort. Use VIG as your floor, not your ceiling, and only add individual names when your investment research reveals a compelling valuation or growth advantage over the index.
The April 2025 tariff-driven selloff temporarily pushed a high-quality dividend growth portfolio to roughly 31% below estimated fair value. Market corrections are historically when the most compelling long-term investment research opportunities emerge — not because you should try to catch a falling knife, but because valuations that were previously stretched suddenly become worth a closer look. Morningstar's fair value framework flagged Accenture (ACN) at approximately 30% below intrinsic value during this window. Building a watchlist of quality dividend growers in advance — so you know exactly what you want to own and at what price — is the key habit that separates reactive investors from prepared ones.
Frequently Asked Questions
Are dividend growth stocks a good investment to research during a market downturn in 2025?
Data from the April 2025 tariff-driven selloff suggests they can be a stabilizing force in a portfolio. A representative top-10 high-growth dividend portfolio lost approximately 3.26% in March 2025, compared to SPY's 5.86% loss — a meaningful gap in a short period. Dividend growth stocks tend to hold up better during drawdowns because companies with decades of consecutive dividend increases typically have stronger cash flows and more conservative financial management. That said, no investment strategy eliminates risk entirely, and investors are watching whether sustained tariff pressures could eventually affect corporate earnings and dividend sustainability in more cyclical sectors.
What is the difference between a high-yield dividend stock and a dividend growth stock — which is better for long-term wealth building?
A high-yield dividend stock pays a large percentage of its current price as dividends right now — think Pfizer's (PFE) close to 7% yield in April 2025. A dividend growth stock may start with a much lower yield (the April 2025 cohort averaged just 1.25%) but grows its payout consistently year after year. Over 10 to 20 years, a stock that raises its dividend 7% annually will eventually deliver a much higher "yield on cost" (your effective yield based on your original purchase price) than a static high-yield stock. For investors in the accumulation phase — building wealth rather than drawing income — dividend growth rate is generally the more important metric, which is why the Seeking Alpha methodology for the April 2025 list explicitly prioritized growth and sustainability over current yield.
How many Dividend Aristocrats are there in 2025 and how do I find the full list?
As of early 2025, there were 69 S&P 500 Dividend Aristocrats — companies with 25 or more consecutive years of dividend increases. Three new members were added in 2025: FactSet Research (FDS), Erie Indemnity (ERIE), and Eversource Energy (ES). The group carries an average dividend yield of 2.1%. You can find the current full list through S&P Global's index methodology page, or track them via the ProShares S&P 500 Dividend Aristocrats ETF (NOBL), which is designed to replicate their collective performance. The Dividend Kings — companies with 50 or more consecutive increases, like Genuine Parts Company (GPC) — are an even more exclusive subset worth researching separately.
Is Pfizer (PFE) a safe dividend stock to research in 2025 given its unusually high 7% yield?
Pfizer's approximately 7% yield in April 2025 puts it firmly in high-yield territory, which always warrants careful stock analysis. High yields can sometimes indicate that a dividend is at risk if earnings do not support it — a pattern known as a yield trap. In Pfizer's case, post-COVID revenue normalization has weighed on the share price, which mechanically pushes the yield higher even if the absolute payout has not changed. The 5-year annualized dividend growth rate of 3.1% and Pfizer's global pharmaceutical supply chain scale suggest the payout has underlying support, but investors are closely watching its drug pipeline, patent cliff exposure, and cost structure before drawing firm conclusions. This one is worth researching further with the most current earnings data and cash flow statements.
Which dividend growth stocks were most undervalued during the April 2025 market crash according to analysts?
Investment research from Morningstar and Seeking Alpha highlighted several names trading meaningfully below estimated fair value during the April 2025 tariff-driven selloff. Accenture (ACN) was flagged by Morningstar at approximately 30% below its fair value estimate, with AI-related professional services cited as a key long-term growth driver. PepsiCo (PEP) and Kimberly-Clark (KMB) were also highlighted by Morningstar analysts as trading below fair value, with expectations of mid-single-digit annual dividend growth going forward. Zooming out, the broader top-10 high-growth dividend cohort tracked by Seeking Alpha was assessed as roughly 31% undervalued in aggregate — a reminder that market trends during sharp corrections often create the research opportunities that patient, data-driven investors spend years waiting for.
Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions.
No comments:
Post a Comment